Medicinal products for human use – Community code OpinionAntagna on 10/06/2009Dokumentreferens: INT/469-EESC-2009-1022Referral: COM(2008) 663 final - 2008/0256 (COD) Rapporteur: Ms Renate Heinisch (Diversity Europe - GR III / Germany) Plenarsession: 454 - Jun 10, 2009 Jun 11, 2009 EESK:s yttrande: Medicinal products for human use – Community codebg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Pharmacovigilance – Community code relating to medicinal products for human use OpinionAntagna on 10/06/2009Dokumentreferens: INT/471-EESC-2009-1024Referral: COM(2008) 665 final – 2008/0260 (COD) Rapporteur: Mr Carmelo Cedrone (Workers - GR II / Italy) Plenarsession: 454 - Jun 10, 2009 Jun 11, 2009 EESK:s yttrande: Pharmacovigilance – Community code relating to medicinal products for human usebg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Pharmacovigilance – Community Regulation – medicinal products for human and veterinary use OpinionAntagna on 10/06/2009Dokumentreferens: INT/470-EESC-2009-1023Referral: COM(2008) 664 final – 2008/0257 (COD) Rapporteur: Ms Sylvia Gauci (Employers - GR I / Malta) Plenarsession: 454 - Jun 10, 2009 Jun 11, 2009 EESK:s yttrande: Pharmacovigilance – Community Regulation – medicinal products for human and veterinary usebg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Medicinal products for human and veterinary use - European Medicines Agency OpinionAntagna on 10/06/2009Dokumentreferens: INT/475-EESC-2009-1025Referral: COM(2008) 662 final - 2008/0255 (COD) Rapporteur: Mr Carmelo Cedrone (Workers - GR II / Italy) Plenarsession: 454 - Jun 10, 2009 Jun 11, 2009 EESK:s yttrande: Medicinal products for human and veterinary use - European Medicines Agencybg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv
Investment initiative in response to coronavirus OpinionDokumentreferens: ECO/515-EESC-2020-01536-00-01-PAC-TRA Referral: COM(2020) 113 final 2020/0043 COD General Rapporteur: Bernd SCHLÜTER Downloads: Position Paper - Regulation on Coronavirus Response Investment Initiativeen fr de